Goals of therapy in common bleeding emergencies

Pharmacotherapy

Volumn 27, Issue 9 II SUPPL., 2007, Pages

  Dutton, Richard P ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

Author keywords

Gastrointestinal bleeding; Hemorrhagic emergencies; Intracranial hemorrhage; Intraoperative bleeding; Trauma

Indexed keywords

ANTICOAGULANT AGENT; BICARBONATE; HEMOSTATIC AGENT; OCTREOTIDE; PROTHROMBIN COMPLEX; PROTON PUMP INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP;

ARTIFICIAL EMBOLISM; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; EMERGENCY; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL HEMORRHAGE; HUMAN; INJURY; REVIEW;

EID: 34548329649     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.9part2.85s     Document Type: Review

References (35)

1. Bick RL. Introduction to thrombosis, proficient and cost-effective approaches to thrombosis. Hematol Oncol Clin North Am 2003;17:1-8.
2. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185-93.
3. American College of Surgeons. International promulgation advanced trauma life support program for doctors. American College of Surgeons 2007. Available from http://www.facs.org/trauma/atls/intnlpromulgation.pdf. Accessed March 15, 2007.
4. Scalea TM, Henry SM. Assessment and initial management in the trauma patient. Probl Anesth 2001;13:271-8.
5. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002;52:1141-6.
6. Moore EE, Thomas G. Orr memorial lecture: staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 1996;172:405-10.
7. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion 2006;46:685-6.
8. Repine TB, Perkins JG, Kauvar DS, Blackborne L. The use of fresh whole blood in massive transfusion. J Trauma 2006;60:S59-69.
9. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma Stress 2007;62:112-19.
10. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German trauma registry on 8724 patients. Injury 2007;38:298-304.
11. Dutton RP. Initial resuscitation of the hemorrhaging patient. In: Speiss B, Shander A, eds. Perioperative transfusion medicine. Philadelphia: Lippincott, Williams & Wilkins, 2006:289-300.
12. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007;62:307-10.
13. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005;59:8-15.
14. Dutton RP, McCunn M, Hyder M, et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004;57:709-18.
15. Stein DM, Dutton RP, O'Connor J, Alexander M, Scalea TM. Determinants of futility of administration of recombinant factor VIIa in trauma. J Trauma 2005;59:609-15.
16. Thomas GO, Dutton RP, Hemlock B, et al. Thromboembolic complications associated with factor VIIa administration. J Trauma 2007;62:564-9.
17. Novo Nordisk. Evaluation of recombinant factor VIIa in patients with severe bleeding. Available from http://clinicaltrials.gov/ct/show/ nct00184548?order=2. Accessed May 29, 2007.
18. Harrison TD, Laskosky J, Jazaeri O, Pasquale MD, Cipolle M. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage. J Trauma 2005;59:150-4.
19. Steiner T, Diringer MN, Schneider D, et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006;59:767-73.
20. Kucher N, Castellanos LR, Quiroz R, Koo S, Fanikos J, Goldhaber SZ. Time trends in warfarin-associated hemorrhage. Am J Cardiol 2004;94:403-6.
21. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-85.
22. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:S204-33.
23. Aguilar MI, Hart RG, Kase CS, et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 2007;82:82-92.
24. MacLaren R. Key concepts in the management of difficult hemorrhagic cases. Pharmacotherapy 2007;27(9 pt 2):S93-102.
25. Voils S. Pharmacologic interventions for the management of critical bleeding. Pharmacotherapy 2007;27(9 pt 2):S69-84.
26. Lindley CM, Sawyer WT, Macik BG, et al. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994;55:638-48.
27. Novo Nordisk. NovoSeven® (coagulation factor VIIa recombinant) prescribing information. Princeton, NJ; October 13, 2006.
28. Roberts HR, Monroe DM, White GC. The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004;104:3858-64.
29. Novo Nordisk. Phase 3 stroke trial shows that NovoSeven® reduces bleeding in the brain, but does not improve long-term clinical outcomes [press release]. Bagsvaerd, Denmark; February 26, 2007. Available from http://www.novonordisk.com/include/asp/exe_news_attachment.pdf?sAttachmentGUID= 2da99205-6e99-4933-9174-2bc77ad5cc4d. Accessed February 26, 2007.
30. Cholongitas E, Senzolo M, Patch D, et al. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006;23:883-93.
31. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane Collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 2007;82:286-96.
32. Gross M, Schiemann U, Muhlhofer A, Zoller WG. Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 2001;33:737-46.
33. Chan MW, Schwaitzberg SD, Demcheva M, Vournakis J, Finkielsztein S, Connolly RJ. Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage. J Trauma 2000;48:454-7.
34. Hirshberg A, Mattox KL. 'Damage control' in trauma surgery. Br J Surg 1993;80:1501-2.
35. Ertel W, Oberholzer A, Platz A, Stocker R, Trentz O. Incidence and clinical pattern of the abdominal compartment syndrome after "damage-control" laparotomy in 311 patients with severe abdominal and/or pelvic trauma. Crit Care Med 2000;28:1747-53.